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Led by four generations of leadership from late Prof. JIANG
Sichang (academician, Chinese Academy of Engineering), Prof.
YANG Weiyan (Honorary President, Division of Otolaryngology
Head and Neck Surgery, Chinese Medical Association), Prof.
HAN Dongyi (President Elected, Division of Otolaryngology
Head and Neck Surgery, Chinese Medical Association) to now
Prof. YANG Shiming (President, Division of Otolaryngologists,
Beijing Medical Doctor Association), the PLA General Hospital
Department of Otolaryngology Head and Neck Surgery has focused
on prevention and treatment of deafness. Prof. JIANG started the
department in 1959. Since then, by the efforts across several
generations over more than half a century, the department has
achieved great accomplishments in many areas including patient
care, teaching and research. The department was made the Center
of Otolaryngology by the PLA General Logistics Department and
approved to award master degrees by the State Education
Commission in 1978. Authorized by the PLA General Logistics
Department, the PLA Institute of Otolaryngology was founded in
1987, which was rated as a national key academic unit by the
State Education Commission in in 1989 (and again in 2002) and
as a PLA key laboratory by the PLA General Logistics Department
in 1992. The department was granted a sub-specialty hospital
status within the PLA General Hospital in 2008 and started building
the Department of Deafness Education Key Laboratory in 2012.
It was awarded the National“973”Project Chief Scientist unit status
in the same year. The department now receives nearly 200,000
outpatient visits a year, and has expanded and branched into
sub-specialties including otology, audiology medicine, rhinology,
head and neck surgeries and pharyngolaryngology and voice
disorders. It runs 200 beds and has 1200 m2 research space
supported by close to RMB 100,000,000 Yuan research funding
for 148 important national and PAL projects. It has won over 100
science and technology progress awards at national and PLA
levels. For many years, the department has been a model unit
within the PLA General Hospital and its showcase unit for visitors.
Today, as a subspecialty hospital that combines patient care,
teaching and research, it enjoys its many sub-specialty divisions,
well recognized services, deep talent reserves and strong expertise
status, and provides first class care to patients from the military as
well as the civilian population. Its graduates and trainees can now
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be seen all over China and across the world and are actively con-
tributing to the advance of otolaryngology and head and neck sur-
gery.
Clinical services
Over the past decades, the department has focused on the treat-
ment and research of deafness and has achieved great accomplish-
ments. Currently, average daily outpatient visits to the department
have reached close to 1,000. Despite the heavy work load and lim-
ited man power, the department strives to ensure the quality as well
as the volume of its expert clinics on daily basis, to maintain high
quality patient care and lab testing, and to secure its outpatient ser-
vices as the first window and platform to providing effective ser-
vices to patients. Its surgeons perform more than 5,000 surgical
procedures each year, more than 30% of which are complex and/
or high-risk cases. As its practice branches out, sub-specialties
including microsurgical otology/neurotology, rhinology/minimal
invasive skull base surgery, head/neck/skull base surgery, audiology
medicine/head and neck oncology, laryngology/voice disorders, fa-
cial plastic and reconstructive surgery, and geriatric care have
been established. Also created in the department are the audito-
ry implantcenter, clinical audiology center, molecular deafness di-
agnosis center, dizziness management center, endoscopy center
and voice medicine center. As the field of otology has rapidly de-
veloped, the traditional view of otology as a surgical discipline is
challenged. A new sub-specialty - audiology medicine was first
founded within the Department of Otolaryngology Head and Neck
Surgery in June 2008, with its separated ward unit allocated in No-
vember 2010. This new sub-specialty unit has made great ad-
vances in management of hearing loss, tinnitus, dizziness and oth-
er inner ear diseases, as well as in managing head and neck oncol-
ogy cases with combined therapies, and continues to explore a
new path in internal medicine otolaryngology suitable for the Chi-
nese patient population.
The department has kept a leading position in the field of mi-
croscopic ear surgery. We were the first to perform inner ear fen-
estration procedures in the 1950s and first to perform stapedecto-
my in 1962 in China. We have performed more than 6,000 stapes
procedures and more than 20,000 cases of middle ear surgeries
to date with high effective rates. In auditory implantation, we
have built a systematic diagnostic and therapeutic approach includ-
ing pre-operative evaluation, minimal invasive cochlear implanta-
tion, post-operative programming, speech rehabilitation, and ge-
netic testing and consultation, by an expert team. Since our first
multi-channel cochlear implantation in 1996, we have completed
over 1,700 cases and we are among the first to adopt new audi-
tory implantation technologies (e.g. Vibrant Soundbridge and
BAHA) and have become the largest auditory implantation center
in China. Diagnosis and treatment of neurotologic diseases is an-
other feature of this department. Our group has performed nearly
350 cases of acoustic neuroma resection (complete resection in
98% ) since the 1980s and we are in a leading position in facial
and auditory function preservation in China. We have also built
leading positions in skull base surgery, rhinology and voice disor-
der treatment in China. The practice scope of our head and neck
surgery group covers treatment of extensive malignancies and be-
nign lesions of the larynx, hypopharynx, temporal bone and infra-
temporal fossa, including procedures such as total and subtotal
temporal bone resection, extended temporal bone resection, resec-
tion of jugular glomous tumors via a combined temporal-cervical
approach, and resection of petroclival tumors, CPA meningioma,
cholesteatoma and choroidal tumors. Our efforts have saved
many lives and are appraised by colleagues as well as patients. In
addition to managing common nasal diseases, our rhinology group
has also expanded its practice to cover anterior skull base and
orbital surgeries. Our laryngology group performs various micro-
scopic vocal cord procedures and voice change surgeries. It also
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provides polysomnography evaluation for sleep apnea and is the
first in China to use da Vinci robot-assisted surgical system in
treating sleep apnea with satisfying results. The group has also
published multiple books and multi-media materials on voice
disorders and voice surgeries. As the department practice continues
to expand with rapidly increasing patient visits and surgery
volumes and no man power supplement, the department leadership
has taken measures to boost the sense of responsibility and service
among personnel at various posts, which helps maintaining a positive
attitude among the staff. In dealing with heavy workloads, the
department advocates its senior faculty as models and relies on
young and middle aged surgeons as the engine work force to
ensure continuous improvement in patient care quality and to
achieve great success in both service and financial gains.
Education
We were authorized by the State Education Commission to
award master’s degrees in 1978 and 61 have graduated from our
master’s program. We were authorized to award doctoral degrees
by the Commission in 1983 and 70 have received their doctoral
degrees from our program. The post-doctoral program was started
in 1992 which has provided training to 8 post-doctoral fellows.
We have also trained 32 graduate students by contract, more than
50 PLA Medical Foundation students, and near 1,000 fellows.
Among graduates from our master’s and doctoral programs are
some senior scientists in Ministry of Science and Technology Key
Scientific Research Project (i.e. the“973”Project), winners of
National Natural Science Funds for Distinguished Young Scholars
grants, winners of PLA Outstanding Talents Awards, winners of
national and PLA best doctoral dissertation awards, and winners of
outstanding master’s dissertation awards. The department staff
consists of patient care, teaching and research personnel with
innovative thinking and capabilities. Of its staff, 17 hold profes-
sorship level and 18 hold associate professorship level rankings.
More than 85% of its senior staff are doctoral graduates, with each
of them focused on and contributing in a field of his/her interests.
In the 1990s, the late Prof. JIANG Sichang was awarded the
“Model Medical Professor” title by the Central Military
Commission. At the beginning of the 21st centery, Prof. YANG
Weiyan was awarded the“BoleAward”by the PLAGeneral Logistics
Department. Profs. HAN Dongyi and YUAN Huijun are winners
of National Natural Science Funds for DistinguishedYoung Scholars
grants. Drs. HANG Dongyi, DAI Bu and WANG Qiuju are
winners of the China Association For Science and Technology
“Qiushi Practical Engineering Awards for Young Scholars”. Drs.
HAN Dongyi, YANG Shiming, WANG Qiuju, DIA Bu, ZHAO
Hui, HUANG Dongyan, HOU Zhaohui, YUAN Yongyi and
WANG Jianguo are winners of PLA General Logistics Department
“Silver Star of Science and Technology”and“Rising Star of
Science and Technology”awards or“Beijing Rising Star of Science
and Technology”awards. The department continues to build a
momentum of advance and growth and will continue to play increas-
ingly influential roles in the advance of patient care and research
in otolaryngology head and neck surgery in China.
The department currently has 4 post-doctoral fellow mentors, 11
doctoral student mentors, 7 master’s student mentors and 13
fellow mentors. Over the decades, we have provided classes for
fellows and residents on every Thursday evening. Many fellows
become senior faculty and leaders of their practice groups after
graduation from our programs. We have sent more than 60 people
overseas for lecturing, fellowship studies and presentations at
international meetings. We have hosted more than 500 international
visitors. We have engaged in extensive academic exchanges with
institutions across the world and have enlisted 12 overseas scholars
as guest professors.
The chairman of the department has traditionally provided
bedside rounds teaching including weekly teaching rounds and
semi-monthly grand rounds, as well as difficult case discussions.
At these discussions, attendees are engaged in analysis of patient
history and test results and formulating opinions of best possible
management plans for the patient’s maximal benefits, based upon
review and discussion of all potential options. It is owing to such
activities that the risk of potentially fatal neck abscess and medias-
tinum infection in a patient with hypopharyngeal foreign body was
identified in time for an emergency drainage procedure to save his
life. In another case of foreign body in the nasopharyngeal skull
base area, an operation plan via an ear-nose combined approach
formulated from such discussions ensured safe removal of the
foreign body. Chairman grand rounds and difficult cases discus-
sions in this department have become effective learning and
exchange experiences for staff at all levels. The department has
also organized international academic activities including the




“Beijing International Forum of Deafness and Genetic Medicine”
and“Beijing International Symposium of Otology”, which have
helped promoting its academic influences. In addition, the depart-
ment has sponsored a number of national level continuous educa-
tion projects, including“Advanced Training Class of Microscopic
Ear Surgery and Neurotology”,“Training Class of Head and Neck
Anatomy and Temporal Bone Surgery”,“Training Class of Clinical
Diagnostic Audiology”,“Training Course of Deafness Gene Diag-
nosis”,“ International Advanced Training Class of Audiology
Medicine”,“Workshop of Nasencoscopy and Skull Base Minimal
Invasive Surgery”and“Training Course of Voice Medicine and
Minimal Invasive Laryngeal Surgery”, which have attracted atten-
dance of experts and students from both China and abroad and
served as an effective platform for exchanges between the depart-
ment and colleagues from China and across the world.
Research
In 1959, the late Prof. JIANG Sichang opened the first laboratory
in the PLA General Hospital with a mere 8 m2 space. Through
development across more than half a century, the PLA Institute of
Otolaryngology now has nine functional laboratories including a
temporal bone pathology laboratory, a auditory and balance physi-
ology laboratory, an otoneurobiology center, and deafness molecu-
lar diagnosis center, a molecular genetics laboratory, and the PLA
Central Station of Medical Acoustic Measurement and Testing,
with equipment valued over RMB 40,000,000 Yuan. The institute
has conducted systematic studies on deafness from the aspects of
molecular biology, cellular biology, embryo development and
genetics, morphology and physiology and clinical audiology. Our
studies have resulted in numerous breakthroughs in inner ear hair
cells regeneration: 1) the first proof of tip-links self-repair following
injury to cochlear hair cell cilia, which provides important
theoretical basis for gene therapies of deafness. The work was
published in a prestigious neuroscience journal, reported a
“waterfall”effect in pathology of hearing damage, proposed a
four-stage hearing damage pathology theory and gene therapy
time window and a strategy of gene therapy to promote hair cell
regeneration; 2) innovative breakthroughs in deafness gene and
molecular therapies. The Math1 gene was found to induce regen-
eration of hair cell cilia with noticeable hearing improvement.
The work was first reported at the ARO annual meeting with great
interests and subsequent studies, and later published on PLoS One
in 2012. The work also found that combined use of the Math1
gene and DAPT led to greatly increased numbers of hair cells in
newborn rats, and that this effect was different at different locations
in the cochlea with variable effects on cilia development. In
collaboration with the National Center for Nanoscience and
Technology, our group has successfully developed a new nanovector,
laying a foundation for future clinical application of gene therapy
for deafness; 3) discovery of new deafness mechanisms. We were
the first to report smad5 as a key gene in aging of hearing and the
work was published in Developmental Neurobiology. We also
found that smad4 defects led to profound hearing loss. This work
was published in Developmental Dynamics and generated great
interests from China and the world. The work discovered that
smad4 defect led to severe abnormality in the development of
inner hair cell ribbon synapses. This discovery is important for
the diagnosis and treatment of auditory neuropathy -a difficult
clinical challenge, allows for new classification of auditory neuro-
ma, and has led to a new concept in hearing restoration strategy
based upon different etiology locations in auditory neuropathy; 4)
new advances in auditory stem cell research; Our in vivo works
have shown that mesenchymal stem cells can be induced to
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differentiate into hair cell-like cells. We have shown that embryo
stem cells can be transported into the cochlea via fenestration in the
basal cochlear turn with good survival rate and minimal damage to
the inner ear. ESCs introduced after ototoxic injury can migrate to
the basilar membrane and vestibule and differentiate into hair
cell-like cells and inner ear neural cells. This work shows a new
horizon in cellular therapy for deafness. Led by Prof. YANG
Shiming as the senior scientist of the“973”Project, his team has
been awarded a greater than RMB 20,000,000 Yuan grant for the
project of“clinical and basic research studies on stem cell therapy
for sensorineural hearing loss”.
Our research in deafness genes has been in a leading position in
China in recent years. Our research platform covers deafness
physiology, pathology, neurobiology, molecular biology and molec-
ular genetics, and includes the largest temporal bone bank in Asia,
an audiology database and a DNA gene bank. Funded by more
than 80 grants from the National Natural Science Foundation and
the“973”and“863”Projects, focused on molecular genetics
mechanisms of deafness, and supported by the abundant heredi-
tary deafness resources in China, we have systematically conducted
research on deafness regarding its causal genes, pathogenesis
mechanisms, and clinical detection and intervention, which has
attracted attention in the field and promoted research on hereditary
deafness in China toward the international levels. These works
won the second prize of National Award for Science and Technology
Progress in 2008 for: 1) consecutive discoveries of two deafness
genes based upon completion of Chinese Population Hereditary
Deafness Database, which facilitated new breakthroughs in research
on mechanisms of deafness; 2) the first report of a new Y-linked
inheritance pattern in hereditary deafness, which is an important
supplement to the theory of hereditary deafness; 3) establishment
of theories and methodologies in prevention of severe sensorineural
hearing loss and in birth defect intervention and their successful
application in prevention and intervention in new born deafness;
4) completion of a national molecular epidemiological survey on
deafness; 5) important progress in studying molecular mecha-
nisms of ototoxic hearing loss for its prevention and treatment; 6)
establishment of a database of presbycusis that allows studies on
hereditary susceptibility to age-related hearing loss at various
levels; 7) proposal of a concept of adding deafness gene testing to
newborn hearing screening protocols and exploration of strategies
and methodologies in combined hearing and gene screening in
newborns; and 8) establishment of the PLA General Hospital
Molecular Diagnosis Center for Deafness, which pioneered utility
of molecular diagnosis of deafness, such as development and
application of 14 patents including the“Mitochondrial DNA
A1555G Mutation Test kit”,“Jingxin 1 Hereditary Deafness
Genes Diagnosis Chip Kit”and“Newborn Deafness Genes Fast
Screening Test Kit”.
Our department has been funded for 148 various research proj-
ects including the National Key Technology R&D Program proj-
ects, National Natural Science Foundation projects, PLA“VIIth
through XIIth Five Year Plans”key projects, National“Xth Five
Year Plan Mandatory Key Technology R&D Program projects,
Ministry of Science and Technology Key Technology R&D
Program projects,“973”projects,“863”projects, Special Founda-
tion for Outstanding Doctoral Graduates projects, NIH funded
projects and Natural Science Foundation of Beijing projects,
worth over RMB 90,000,000 Yuan. Through these works, achieve-
ments have been accomplished on pathogenesis, prevention and
treatment of noise-induced hearing loss, ototoxic hearing loss, sud-
den deafness and hereditary deafness, cloning of deafness genes,
hearing screening in newborns, pre-natal screening of hereditary
deafness, auditory implantation, neurotology, lateral skull base
surgery, head and neck surgery, nasal surgery, voice surgery and
biological therapies for deafness. Its faculties and scientists have
published 1543 papers, including more than 150 indexed in SCI
with the highest impact factor at 12.34, and 38 books. Among the
over 100 honors awarded to the department are 4 second and 1
third prizes of National S&T Progress Award, 1 second prize of
Department of Education S&T Progress Award, 2 first and 24 sec-
ond prizes of PLA S&T Progress Award, and 1 first and 3 second
prizes of Beijing S&T Progress Award.
In addition to continuously improving patient care, teaching and
research, the department created the“Chinese Journal of Otology”
in 2003 and the sole English language otology journal in Asia - the
“Journal of Otology”in 2006. The Chinese Journal of Otology is
now indexed by Chinese Core Periodicals, Chinese Science and
Technology Core Periodicals and Chinese Science Citation Data-
base. Through its more than a decade’s efforts, the journal has
built its distinct columns, with increasing influences. Its impact
factor ranks first among the 25 ENT journals in China, with the
highest numbers of grant funded papers. It is a must read for
Chinese otolaryngologists.
Following the foregoing generations of leaderships under Profs.
JIANG Sichang, YANG Weiyan and HAN Dongyi, it is expected
that the fourth generation leader - Prof. YANG Shiming will lead
the PLA General Hospital Department of Otolaryngology Head
and Neck Surgery in writing its new ever more glorious chapters.
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